|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.49/-1.94
|
企業價值
57.86M
|
資產負債 |
每股賬面淨值
3.96
|
現金流量 |
現金流量率
--
|
損益表 |
收益
802.00K
|
每股收益
0.33
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/12/24 12:52 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer. |